The estimated Net Worth of Andrew Reardon is at least $2.5 Milione dollars as of 28 August 2024. Andrew Reardon owns over 1,500 units of Ligand Pharmaceuticals stock worth over $2,477,665 and over the last 2 years Andrew sold LGND stock worth over $20,976.
Andrew has made over 3 trades of the Ligand Pharmaceuticals stock since 2023, according to the Form 4 filled with the SEC. Most recently Andrew exercised 1,500 units of LGND stock worth $78,405 on 28 August 2024.
The largest trade Andrew's ever made was exercising 10,000 units of Ligand Pharmaceuticals stock on 9 May 2024 worth over $522,700. On average, Andrew trades about 1,180 units every 52 days since 2022. As of 28 August 2024 Andrew still owns at least 24,034 units of Ligand Pharmaceuticals stock.
You can see the complete history of Andrew Reardon stock trades at the bottom of the page.
Andrew's mailing address filed with the SEC is 555 HERITAGE DRIVE, SUITE 200, JUPITER, FL, 33458.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... e Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: